Formulation Progress, Challenges, and Perspectives of Anti-Inflammatory Natural Products
Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-42
DOI: 10.2147/dddt.s606531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Hongran Fang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, People's Republic of China. Hauptthemen laut MEDLINE: Biological Products, Anti-Inflammatory Agents, Inflammation. Die Arbeit nennt 183 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
- Department of Anesthesiology, The Second People's Hospital of Neijiang, Southwest Medical University, Neijiang, Sichuan, People's Republic of China.
ORCID-Profile: Hongran Fang, Muxin Zhao, Hao Liu
Zitieren
APA
Fang, H., Wu, A., Zhao, M., Nan, X., Yang, L., & Liu, H. (2026). Formulation Progress, Challenges, and Perspectives of Anti-Inflammatory Natural Products. Drug Design, Development and Therapy, Volume 20, 1-42. https://doi.org/10.2147/dddt.s606531
Vancouver
Fang H, Wu A, Zhao M, Nan X, Yang L, Liu H. Formulation Progress, Challenges, and Perspectives of Anti-Inflammatory Natural Products. Drug Design, Development and Therapy. 2026;Volume 20:1-42. doi:10.2147/dddt.s606531
BibTeX
@article{Fang2026,
author = {Fang, Hongran and Wu, Ailing and Zhao, Muxin and Nan, Xichen and Yang, Luhan and Liu, Hao},
title = {Formulation Progress, Challenges, and Perspectives of Anti-Inflammatory Natural Products},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--42},
doi = {10.2147/dddt.s606531}
}
EUVIMED